TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,004,000 | -54.9% | 13,338 | -83.9% | 0.01% | -68.4% |
| Q1 2022 | $2,225,000 | +116.9% | 82,853 | +285.2% | 0.02% | +90.0% |
| Q4 2021 | $1,026,000 | -21.4% | 21,508 | +9.5% | 0.01% | -37.5% |
| Q3 2021 | $1,305,000 | -31.4% | 19,650 | -19.4% | 0.02% | -23.8% |
| Q2 2021 | $1,902,000 | -45.8% | 24,377 | -34.3% | 0.02% | -53.3% |
| Q1 2021 | $3,511,000 | +52.3% | 37,117 | +96.2% | 0.04% | +40.6% |
| Q4 2020 | $2,305,000 | +78.0% | 18,917 | +27.6% | 0.03% | +68.4% |
| Q3 2020 | $1,295,000 | +340.5% | 14,825 | +125.4% | 0.02% | +137.5% |
| Q1 2020 | $294,000 | -79.2% | 6,578 | -71.0% | 0.01% | -69.2% |
| Q4 2019 | $1,413,000 | +1470.0% | 22,688 | +924.3% | 0.03% | +1200.0% |
| Q2 2019 | $90,000 | – | 2,215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |